Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive memantine for chronic schizophrenia
IRCT201306015605N1Phase 2Completed
- Sponsor
- Clinical Psychiatry Research Center, Tabriz University of Medical Sciences
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine in schizophrenia, sponsored by Clinical Psychiatry Research Center, Tabriz University of Medical Sciences. Started Nov 2012; status: completed.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201306015605N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201306015605N1.